These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 36219557)
1. Construction of an rAAV Producer Cell Line through Synthetic Biology. Lee Z; Lu M; Irfanullah E; Soukup M; Hu WS ACS Synth Biol; 2022 Oct; 11(10):3285-3295. PubMed ID: 36219557 [TBL] [Abstract][Full Text] [Related]
2. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap. Conway JE; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ J Virol; 1997 Nov; 71(11):8780-9. PubMed ID: 9343238 [TBL] [Abstract][Full Text] [Related]
3. Comparative transcriptomic and proteomic kinetic analysis of adeno-associated virus production systems. Lin YC; Lu M; Cai W; Hu WS Appl Microbiol Biotechnol; 2024 Jun; 108(1):385. PubMed ID: 38896252 [TBL] [Abstract][Full Text] [Related]
4. A helper virus-free packaging system for recombinant adeno-associated virus vectors. Collaco RF; Cao X; Trempe JP Gene; 1999 Oct; 238(2):397-405. PubMed ID: 10570967 [TBL] [Abstract][Full Text] [Related]
5. Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines. Liu X; Voulgaropoulou F; Chen R; Johnson PR; Clark KR Mol Ther; 2000 Oct; 2(4):394-403. PubMed ID: 11020356 [TBL] [Abstract][Full Text] [Related]
6. Replication of rep-cap genes is essential for the high-efficiency production of recombinant AAV. Fan PD; Dong JY Hum Gene Ther; 1997 Jan; 8(1):87-98. PubMed ID: 8989998 [TBL] [Abstract][Full Text] [Related]
8. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap. Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400 [TBL] [Abstract][Full Text] [Related]
9. Construction of adeno-associated virus packaging plasmids and cells that directly select for AAV helper functions. Whiteway A; Deru W; Prentice HG; Anderson R J Virol Methods; 2003 Dec; 114(1):1-10. PubMed ID: 14599673 [TBL] [Abstract][Full Text] [Related]
10. Development of an Inducible, Replication-Competent Assay Cell Line for Titration of Infectious Recombinant Adeno-Associated Virus Vectors. Lee Z; Lu M; Irfanullah E; Soukup M; Schmidt D; Hu WS Hum Gene Ther; 2023 Feb; 34(3-4):162-170. PubMed ID: 36565023 [TBL] [Abstract][Full Text] [Related]
11. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. Xiao X; Li J; Samulski RJ J Virol; 1998 Mar; 72(3):2224-32. PubMed ID: 9499080 [TBL] [Abstract][Full Text] [Related]
12. Tuning capsid formation dynamics in recombinant adeno-associated virus producing synthetic cell lines to enhance full particle productivity. Lu M; Lin YC; Kuo HJ; Cai W; Ye Q; Zhao L; Hu WS Biotechnol J; 2024 Mar; 19(3):e2400051. PubMed ID: 38479988 [TBL] [Abstract][Full Text] [Related]
13. Efficient production of dual recombinant adeno-associated viral vectors for factor VIII delivery. Wang Q; Dong B; Firrman J; Roberts S; Moore AR; Cao W; Diao Y; Kapranov P; Xu R; Xiao W Hum Gene Ther Methods; 2014 Aug; 25(4):261-8. PubMed ID: 25093498 [TBL] [Abstract][Full Text] [Related]
14. Enhancing the production of recombinant adeno-associated virus in synthetic cell lines through systematic characterization. Lu M; Lee Z; Lin YC; Irfanullah I; Cai W; Hu WS Biotechnol Bioeng; 2024 Jan; 121(1):341-354. PubMed ID: 37749931 [TBL] [Abstract][Full Text] [Related]
15. Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome. Chadeuf G; Favre D; Tessier J; Provost N; Nony P; Kleinschmidt J; Moullier P; Salvetti A J Gene Med; 2000; 2(4):260-8. PubMed ID: 10953917 [TBL] [Abstract][Full Text] [Related]
17. OneBac: platform for scalable and high-titer production of adeno-associated virus serotype 1-12 vectors for gene therapy. Mietzsch M; Grasse S; Zurawski C; Weger S; Bennett A; Agbandje-McKenna M; Muzyczka N; Zolotukhin S; Heilbronn R Hum Gene Ther; 2014 Mar; 25(3):212-22. PubMed ID: 24299301 [TBL] [Abstract][Full Text] [Related]
18. A concept of eliminating nonhomologous recombination for scalable and safe AAV vector generation for human gene therapy. Dong B; Moore AR; Dai J; Roberts S; Chu K; Kapranov P; Moss B; Xiao W Nucleic Acids Res; 2013 Jul; 41(13):6609-17. PubMed ID: 23677609 [TBL] [Abstract][Full Text] [Related]
19. Improved Genome Packaging Efficiency of Adeno-associated Virus Vectors Using Rep Hybrids. Mietzsch M; Eddington C; Jose A; Hsi J; Chipman P; Henley T; Choudhry M; McKenna R; Agbandje-McKenna M J Virol; 2021 Sep; 95(19):e0077321. PubMed ID: 34287038 [TBL] [Abstract][Full Text] [Related]
20. AAV production in stable packaging cells requires expression of adenovirus 22/33K protein to allow episomal amplification of integrated rep/cap genes. Su W; Seymour LW; Cawood R Sci Rep; 2023 Dec; 13(1):21670. PubMed ID: 38066084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]